Isomorphic Labs
| Type | Subsidiary |
|---|---|
| Industry | Drug discovery |
| Founded | 24 February 2021 |
| Founder | Demis Hassabis |
| Headquarters | London, England |
| Key people | |
| Owner | Alphabet Inc. |
| Website | www |
Isomorphic Labs Limited is a British multinational artificial intelligence company based in London, England. Isomorphic Labs was founded by Demis Hassabis, who is the CEO. The company was incorporated on February 24, 2021 and announced on November 4, 2021. It was established under Alphabet Inc. as a spin-off from its AI research lab DeepMind, which Hassabis co-founded and now chairs after stepping down as CEO.
The company draws upon DeepMind's AlphaFold technology, which can be used to predict protein structures in the human body with high accuracy, allowing its researchers to find new target pathways for drug delivery.